120 related articles for article (PubMed ID: 3428333)
1. Continuous infusion of high-dose cisplatin in children: pharmacokinetics of free and total platinum.
Bues-Charbit M; Gentet JC; Bernard JL; Breant V; Cano JP; Raybaud C
Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1649-52. PubMed ID: 3428333
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic evaluation of continuous infusion cisplatin].
Hiura M; Takenawa J; Ryoji O; Taki Y; Hyashi T; Kiriyama T
Hinyokika Kiyo; 1989 Jun; 35(6):955-61. PubMed ID: 2801396
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of aqua (1,1-bis(aminomethyl)cyclohexane) sulfatoplatinum (II) (spiroplatin) during a phase I trial.
van der Vijgh WJ; Elferink F; Vermorken JB; ten Bokkel Huinink WW; Klein I; Gall HE; Simonetti G; McVie JG; Pinedo HM
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):621-7. PubMed ID: 3383966
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients.
Gouyette A; Apchin A; Foka M; Richard JM
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):257-63. PubMed ID: 3709595
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
Belliveau JF; Posner MR; Ferrari L; Crabtree GW; Cummings FJ; Wiemann MC; O'Leary GP; Griffin H; Phaneuf MA; O'Rourke A
Cancer Treat Rep; 1986 Oct; 70(10):1215-7. PubMed ID: 3756943
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cisplatin in combined cisplatin and 5-fluorouracil therapy: a comparative study of three different schedules of cisplatin administration.
Ikeda K; Terashima M; Kawamura H; Takiyama I; Koeda K; Takagane A; Sato N; Ishida K; Iwaya T; Maesawa C; Yoshinari H; Saito K
Jpn J Clin Oncol; 1998 Mar; 28(3):168-75. PubMed ID: 9614438
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.
Vermorken JB; van der Vijgh WJ; Klein I; Hart AA; Gall HE; Pinedo HM
Cancer Treat Rep; 1984 Mar; 68(3):505-13. PubMed ID: 6538459
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin.
Vermorken JB; van der Vijgh WJ; Klein I; Gall HE; van Groeningen CJ; Hart GA; Pinedo HM
Clin Pharmacol Ther; 1986 Feb; 39(2):136-44. PubMed ID: 3943271
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin pharmacokinetics in children with cancer.
Peng B; English MW; Boddy AV; Price L; Wyllie R; Pearson AD; Tilby MJ; Newell DR
Eur J Cancer; 1997 Oct; 33(11):1823-8. PubMed ID: 9470840
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors.
Dominici C; Petrucci F; Caroli S; Alimonti A; Clerico A; Castello MA
J Clin Oncol; 1989 Jan; 7(1):100-7. PubMed ID: 2909663
[TBL] [Abstract][Full Text] [Related]
11. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of carboplatin.
Oguri S; Sakakibara T; Mase H; Shimizu T; Ishikawa K; Kimura K; Smyth RD
J Clin Pharmacol; 1988 Mar; 28(3):208-15. PubMed ID: 3283185
[TBL] [Abstract][Full Text] [Related]
13. cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach.
Morazzoni F; Canevali C; Zucchetti M; Caroli S; Alimonti A; Petrucci F; Giudice G; Masoni E; Bedini AV
J Cancer Res Clin Oncol; 1998 Jan; 124(1):37-43. PubMed ID: 9498833
[TBL] [Abstract][Full Text] [Related]
14. Test dose-guided administration of cisplatin in an anephric patient: a case report.
Ribrag V; Droz JP; Morizet J; Leclercq B; Gouyette A; Chabot GG
Ann Oncol; 1993 Sep; 4(8):679-82. PubMed ID: 8240999
[TBL] [Abstract][Full Text] [Related]
15. Correlation between free platinum AUC and total platinum measurement 24 h after i.v. bolus injection of cisplatin in humans.
Fournier C; Vennin P; Hecquet B
Cancer Chemother Pharmacol; 1988; 21(1):75-7. PubMed ID: 3342469
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients.
Erdlenbruch B; Nier M; Kern W; Hiddemann W; Pekrun A; Lakomek M
Eur J Clin Pharmacol; 2001 Aug; 57(5):393-402. PubMed ID: 11599657
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors.
Bonetti A; Franceschi T; Apostoli P; Messori A; Sperotto L; Cetto GL; Molino A; Leone R
Ther Drug Monit; 1995 Feb; 17(1):25-32. PubMed ID: 7725373
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion.
Cano JP; Catalin J; Rigault JP; Bues-Charbit M; Placidi M; Raybaud C; Bernard JL
Biomedicine; 1981 Dec; 34(3):146-53. PubMed ID: 7199945
[TBL] [Abstract][Full Text] [Related]
19. Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.
Holding JD; Lindup WE; Bowdler DA; Siodlak MZ; Stell PM
Br J Clin Pharmacol; 1991 Aug; 32(2):173-9. PubMed ID: 1931468
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
